Adirondack Cancer Center — Glens Falls, New York

Adirondack Cancer Center is a clinical research site located in Glens Falls, New York, United States 12801.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Adirondack Cancer Center has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Sponsors: National Cancer Institute (NCI), ETOP IBCSG Partners Foundation.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adirondack Cancer Center?

Adirondack Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adirondack Cancer Center conducted?

Adirondack Cancer Center has 13 clinical trials on record, with 3 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Is Adirondack Cancer Center accredited by Crixeo Health?

Yes — Adirondack Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Adirondack Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.